- April 7, 2020
CarthroniX begins IND-filing procedure for a Phase 1/2a clinical trial
to test CX-011 as a disease modifying therapy for moderate
osteoarthritis of the knee. CX-011 has shown strong regenerative and
pain suppressive effects as well as an excellent safety profile in pre-
clinical studies. The clinical trial is scheduled for Q2 2021.